Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Trial Profile

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Phase of Trial: Phase II

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Chemotherapy-induced damage; Heart disorders
  • Focus Therapeutic Use
  • Acronyms PREVENT
  • Most Recent Events

    • 17 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
    • 17 Apr 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2017.
    • 24 Feb 2014 Status changed from not yet recruiting to recruiting as reported by record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top